The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy

BackgroundPostoperative nausea and vomiting (PONV) frequently develops in patients undergoing thyroidectomy, and propofol-based total intravenous anesthesia (TIVA) has been reported to reduce the incidence of PONV. The present study was undertaken to compare the effects of ramosetron on PONV in wome...

Full description

Bibliographic Details
Main Authors: Dong Chul Lee, Hyun Jeong Kwak, Hong Soon Kim, Sung Ho Choi, Ji Yeon Lee
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2011-08-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kjae-61-154.pdf
_version_ 1818348697272975360
author Dong Chul Lee
Hyun Jeong Kwak
Hong Soon Kim
Sung Ho Choi
Ji Yeon Lee
author_facet Dong Chul Lee
Hyun Jeong Kwak
Hong Soon Kim
Sung Ho Choi
Ji Yeon Lee
author_sort Dong Chul Lee
collection DOAJ
description BackgroundPostoperative nausea and vomiting (PONV) frequently develops in patients undergoing thyroidectomy, and propofol-based total intravenous anesthesia (TIVA) has been reported to reduce the incidence of PONV. The present study was undertaken to compare the effects of ramosetron on PONV in women following total thyroidectomy under TIVA.MethodsOne hundred and thirty women scheduled for thyroidectomy were allocated to either a control group (n = 65) or a ramosetron group (n = 65). Propofol in combination with remifentanil was used for TIVA in all patients. 2 ml of either intravenous saline (control group) or 0.3 mg of ramosetron (ramosetron group) were administered at the end of the surgery. Fentanyl-based patient-controlled analgesia was implemented for 48 h after surgery in all patients. The incidences and severities of PONV, pain scores, administrations of rescue antiemetics, and the side effects of the antiemetics were documented during the first 48 h after surgery.ResultsThe incidences of complete response (no PONV, no rescue) in the control and ramosetron groups were 71% and 88%, respectively, during the first 6 h (P = 0.029), 85% and 94% during the next 6 to 24 h period (P = 0.155), and 97% and 95% during the last 24 to 48 h period (P = 1.00). During the first 6 h, the severity of nausea and the use of rescue antiemetic medication were significantly lower in the ramosetron group.ConclusionsRamosetron was found to be effective at reducing the incidence and severity of postoperative nausea in women that underwent total thyroidectomy with propofol-based TIVA, especially during the first 6 hours postoperatively.
first_indexed 2024-12-13T17:54:10Z
format Article
id doaj.art-2ace6a6f59e646de9d4d85c19cd38100
institution Directory Open Access Journal
issn 2005-6419
2005-7563
language English
last_indexed 2024-12-13T17:54:10Z
publishDate 2011-08-01
publisher Korean Society of Anesthesiologists
record_format Article
series Korean Journal of Anesthesiology
spelling doaj.art-2ace6a6f59e646de9d4d85c19cd381002022-12-21T23:36:25ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632011-08-0161215415810.4097/kjae.2011.61.2.1547173The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomyDong Chul Lee0Hyun Jeong Kwak1Hong Soon Kim2Sung Ho Choi3Ji Yeon Lee4Department of Anesthesiology and Pain Medicine, Gachon University of Medicine and Science, Incheon, Korea.Department of Anesthesiology and Pain Medicine, Gachon University of Medicine and Science, Incheon, Korea.Department of Anesthesiology and Pain Medicine, Gachon University of Medicine and Science, Incheon, Korea.Department of Anesthesiology and Pain Medicine, Gachon University of Medicine and Science, Incheon, Korea.Department of Anesthesiology and Pain Medicine, Gachon University of Medicine and Science, Incheon, Korea.BackgroundPostoperative nausea and vomiting (PONV) frequently develops in patients undergoing thyroidectomy, and propofol-based total intravenous anesthesia (TIVA) has been reported to reduce the incidence of PONV. The present study was undertaken to compare the effects of ramosetron on PONV in women following total thyroidectomy under TIVA.MethodsOne hundred and thirty women scheduled for thyroidectomy were allocated to either a control group (n = 65) or a ramosetron group (n = 65). Propofol in combination with remifentanil was used for TIVA in all patients. 2 ml of either intravenous saline (control group) or 0.3 mg of ramosetron (ramosetron group) were administered at the end of the surgery. Fentanyl-based patient-controlled analgesia was implemented for 48 h after surgery in all patients. The incidences and severities of PONV, pain scores, administrations of rescue antiemetics, and the side effects of the antiemetics were documented during the first 48 h after surgery.ResultsThe incidences of complete response (no PONV, no rescue) in the control and ramosetron groups were 71% and 88%, respectively, during the first 6 h (P = 0.029), 85% and 94% during the next 6 to 24 h period (P = 0.155), and 97% and 95% during the last 24 to 48 h period (P = 1.00). During the first 6 h, the severity of nausea and the use of rescue antiemetic medication were significantly lower in the ramosetron group.ConclusionsRamosetron was found to be effective at reducing the incidence and severity of postoperative nausea in women that underwent total thyroidectomy with propofol-based TIVA, especially during the first 6 hours postoperatively.http://ekja.org/upload/pdf/kjae-61-154.pdfpatient-controlled analgesiapostoperative nausea and vomitingpropofolramosetronthyroidectomy
spellingShingle Dong Chul Lee
Hyun Jeong Kwak
Hong Soon Kim
Sung Ho Choi
Ji Yeon Lee
The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
Korean Journal of Anesthesiology
patient-controlled analgesia
postoperative nausea and vomiting
propofol
ramosetron
thyroidectomy
title The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
title_full The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
title_fullStr The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
title_full_unstemmed The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
title_short The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
title_sort preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy
topic patient-controlled analgesia
postoperative nausea and vomiting
propofol
ramosetron
thyroidectomy
url http://ekja.org/upload/pdf/kjae-61-154.pdf
work_keys_str_mv AT dongchullee thepreventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy
AT hyunjeongkwak thepreventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy
AT hongsoonkim thepreventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy
AT sunghochoi thepreventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy
AT jiyeonlee thepreventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy
AT dongchullee preventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy
AT hyunjeongkwak preventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy
AT hongsoonkim preventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy
AT sunghochoi preventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy
AT jiyeonlee preventativeeffectoframosetrononpostoperativenauseaandvomitingaftertotalthyroidectomy